STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 98 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 2.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $423,000 | -52.5% | 87,400 | +4.3% | 0.00% | -100.0% |
| Q4 2019 | $891,000 | +3.6% | 83,800 | +1.5% | 0.00% | 0.0% |
| Q3 2019 | $860,000 | -12.9% | 82,600 | +28.3% | 0.00% | 0.0% |
| Q2 2019 | $987,000 | +9.1% | 64,400 | -8.5% | 0.00% | 0.0% |
| Q1 2019 | $905,000 | +93.4% | 70,400 | +42.8% | 0.00% | 0.0% |
| Q4 2018 | $468,000 | +198.1% | 49,300 | +540.3% | 0.00% | 0.0% |
| Q1 2014 | $157,000 | +51.0% | 7,700 | +45.3% | 0.00% | – |
| Q4 2013 | $104,000 | – | 5,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eventide Asset Management | 579,800 | $7,224,000 | 1.01% |
| VHCP Management, LLC | 71,000 | $884,000 | 0.40% |
| Healthcare Value Capital, LLC | 16,464 | $205,000 | 0.20% |
| CARL DOMINO INC | 22,196 | $277,000 | 0.15% |
| TFS CAPITAL LLC | 120,112 | $1,497,000 | 0.13% |
| Private Capital Advisors, Inc. | 31,064 | $387,000 | 0.12% |
| Artal Group S.A. | 170,000 | $2,118,000 | 0.08% |
| TimesSquare Capital Management, LLC | 801,225 | $9,983,000 | 0.06% |
| Baker Brothers Advisors | 338,671 | $4,220,000 | 0.05% |
| STONERIDGE INVESTMENT PARTNERS LLC | 19,399 | $242,000 | 0.04% |